Last reviewed · How we verify

NCT05833048

Rectus Sheath Block in Cardiac Surgery

Recruiting now NA Last updated 23 September 2025
What this trial tests

NA trial testing Rectus sheath block in Cardiac Disease in 75 participants. Currently enrolling.

Timeline
29 July 2024
Primary endpoint
30 March 2026
7 September 2026

Quick facts

Lead sponsorIcahn School of Medicine at Mount Sinai
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment75
Start date29 July 2024
Primary completion30 March 2026
Estimated completion7 September 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Icahn School of Medicine at Mount Sinai

Who can join

Adults 18 to 85, any sex, with Cardiac Disease or Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, randomized study. The purpose of this study is to evaluate the effect of post-surgical pain control of a type of peripheral nerve block, Rectus Sheath Block. 1. Does the rectus sheath block decrease opioid consumption postoperatively after cardiac surgery? 2. Does the rectus sheath block decrease VAS pain scores postoperatively after cardiac surgery? Study participants will be assigned to receive either rectus sheath block or no block.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Rectus sheath block

Trials testing the same drug.

Other recruiting trials for Cardiac Disease

Currently open trials in the same condition.

Other Icahn School of Medicine at Mount Sinai trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05833048.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing